Literature DB >> 3705960

Bannayan syndrome--generalized lipomatosis associated with megalencephaly and macrodactyly.

K Okumura, Y Sasaki, M Ohyama, T Nishi.   

Abstract

This paper reports an autopsy case of a 5-year and 11-month-old girl with generalized subcutaneous lipomatosis, megalencephaly, and macrodactyly. Marked emaciation and poor prognosis were the characteristic findings of this case. We thought that this case was identical with a rare syndrome which was initially reported by BANNAYAN in 1971. Autopsy disclosed diffuse lipomatosis in the thoracic and abdominal cavity, and infiltration of fat tissue to the pancreas. Hyperplasia of the small intestinal mucosa and Peyer's patch, and a pedunculated polyp of the sigmoid colon were the unique findings which could not be seen in the previously reported cases.

Entities:  

Mesh:

Year:  1986        PMID: 3705960     DOI: 10.1111/j.1440-1827.1986.tb01479.x

Source DB:  PubMed          Journal:  Acta Pathol Jpn        ISSN: 0001-6632


  4 in total

1.  Case report 509: Proteus syndrome.

Authors:  M I Burnstein; S R Kottamasu; L Weiss; M E Katz
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

2.  The histopathology of PRSS1 hereditary pancreatitis.

Authors:  Aatur D Singhi; Reetesh K Pai; Jeffrey A Kant; Tanner L Bartholow; Herbert J Zeh; Kenneth K Lee; Martin Wijkstrom; Dhiraj Yadav; Rita Bottino; Randall E Brand; Jennifer S Chennat; Mark E Lowe; Georgios I Papachristou; Adam Slivka; David C Whitcomb; Abhinav Humar
Journal:  Am J Surg Pathol       Date:  2014-03       Impact factor: 6.394

3.  Lipomatous pseudohypertrophy of the pancreas: a clinicopathologically distinct entity.

Authors:  Deniz Altinel; Olca Basturk; Juan M Sarmiento; Diego Martin; Michael J Jacobs; David A Kooby; N Volkan Adsay
Journal:  Pancreas       Date:  2010-04       Impact factor: 3.327

4.  Proteus syndrome versus Bannayan-Zonana syndrome: a problem in differential diagnosis.

Authors:  M G Bialer; M J Riedy; W G Wilson
Journal:  Eur J Pediatr       Date:  1988-11       Impact factor: 3.183

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.